Jul 7, 2026 08:03AM
Jul 7, 2026 08:00AM
Jun 30, 2026 08:01AM
Jun 30, 2026 08:00AM
Jun 18, 2026 08:00AM
Jun 18, 2026 08:00AM
May 15, 2026 04:30PM Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
May 5, 2026 08:00AM
May 5, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 27, 2026 08:00AM
Apr 21, 2026 08:02AM
Apr 21, 2026 08:00AM
Mar 31, 2026 08:00AM Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress
Mar 31, 2026 08:00AM
Mar 6, 2026 08:01AM
Mar 6, 2026 08:00AM
Mar 6, 2026 08:00AM
Mar 6, 2026 08:00AM
Feb 18, 2026 08:15AM
Feb 18, 2026 08:15AM Allarity Therapeutics Doses First Patients in VA-Funded Phase 2 Trial Focused on Small Cell Lung Cancer with High Unmet Need
Feb 3, 2026 08:00AM
Feb 3, 2026 08:00AM
Dec 31, 2025 08:00AM
Nov 14, 2025 09:00AM
Sep 22, 2025 08:01AM
Sep 22, 2025 08:00AM
Aug 26, 2025 08:00AM Allarity receives FDA fast track designation for ovarian cancer drug
Aug 26, 2025 08:00AM
Jun 2, 2025 08:00AM
Jun 2, 2025 08:00AM
May 9, 2025 04:05PM
Apr 25, 2025 08:01AM
Apr 25, 2025 08:00AM
Mar 31, 2025 04:05PM Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
Mar 13, 2025 08:33AM
Mar 13, 2025 08:30AM
Mar 6, 2025 08:00AM
Feb 24, 2025 08:00AM
Feb 6, 2025 08:01AM
Feb 6, 2025 08:00AM
Jan 30, 2025 08:06AM Allarity Therapeutics (ALLR) Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC
Jan 30, 2025 08:00AM
Nov 18, 2024 08:03AM
Nov 18, 2024 08:00AM
Nov 14, 2024 08:00AM
Oct 18, 2024 12:47PM
Jul 22, 2024 06:32AM
Jul 22, 2024 06:30AM Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives
Jun 25, 2024 08:00AM

325,888 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All